Scopus h-index:40
- Home
- Profiles


Michael J Donovan, PhD, MD
- About Me
- Locations
- Publications
About Me
Language
Position
About Me
Language
Position
About Me
Language
Position
Locations
Publications
Article:97
Review Article:7
Comment/Debate:2
Letter:2
Chapter:3
Recent Artifacts
- Development and validation of an AI-enabled digital breast cancer assay to predict early-stage breast cancer recurrence within 6 years
- Global DNA methylation of WTC prostate cancer tissues show signature differences compared to non-exposed cases
- Pre-diagnosis urine exosomal RNA (ExoDx EPI score) is associated with post-prostatectomy pathology outcome
- Association of mutations in DNA polymerase epsilon with increased CD8+ cell infiltration and prolonged progression-free survival in patients with meningiomas
- Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies
- Real World Evidence and Clinical Utility of KidneyIntelX on Patients With Early-Stage Diabetic Kidney Disease: Interim Results on Decision Impact and Outcomes
- ARID1A mutation associated with recurrence and shorter progression-free survival in atypical meningiomas
- Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification
- NF2 mutations are associated with resistance to radiation therapy for grade 2 and grade 3 recurrent meningiomas
- Analytical validation of a multi-biomarker algorithmic test for prediction of progressive kidney function decline in patients with early-stage kidney disease